Debevoise Advises HCA Healthcare in Its Divestiture of Its Brookdale Health Care Services Joint Venture to LHC Group

28 September 2021

Debevoise & Plimpton LLP is advising HCA Healthcare, Inc. (NYSE:HCA) in its agreement to divest certain assets from its newly formed home health, hospice and outpatient therapy joint venture with Brookdale Health Care services – the home health, hospice and outpatient therapy business of Brookdale Senior Living Inc. (NYSE:BKD) – to LHC Group, Inc. (NASDAQ: LHCG). Under the agreement, LHC will purchase several Brookdale Health Care Services agencies from the joint venture including 23 home health locations, 11 hospice and 13 therapy agencies across 22 states. The agencies will continue to operate under their existing brands and locations. For more information, please see LHC’s press release.

HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 187 hospitals and approximately 2,000 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics the U.S. and U.K. LHC Group is a national provider of in-home healthcare with 30,000 employees across home health, hospice, home and community based services and facility-based care in the U.S.

The Debevoise team is led by M&A partner Jennifer Chu and includes associates David Becker, Marisa Demko, Dane Dixon, Margaret Howard and TC Huang and benefits partner Simone Hicks and associate Zain Kazmi.